Related Experiment Video
Updated: Sep 25, 2026

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
Epidermal growth factor receptor is a marker for syncytiotrophoblastic cells in testicular germ cell tumors
Lukas Hechelhammer1, Stephan Störkel, Bernhard Odermatt
1Institute of Clinical Pathology, Department of Pathology, University Hospital, Schmelzbergstrasse 12, 8091, Zürich, Switzerland.
Abstract:
The epidermal growth factor receptor (EGFR) has been implicated in the pathogenesis, therapy and prognosis of various tumor types. The aim of this study was to investigate EGFR expression in a large series of testicular germ cell tumors (TGCTs). A total of 88 TGCTs (37 of pure type and 51 of mixed type) comprising a total of 44 seminoma, 49 embryonal carcinoma, 32 yolk sac tumor, 28 teratoma and 7 choriocarcinoma components were immunostained for EGFR. EGFR reactivity was observed in the stromal cells of embryonal carcinoma (29%) and in epithelial compartments of teratoma (71%). In addition, EGFR staining was consistently detected in syncytiotrophoblastic cells of choriocarcinoma, seminoma, embryonal carcinoma and yolk sac tumor components. EGFR staining, similar to beta-human chorionic gonadotropin (HCG) immunohistochemistry, was efficiently able to identify syncytiotrophoblastic cells in TGCTs. This study shows that EGFR is expressed in a subset of testicular germ cell tumors and suggests that EGFR may be a useful marker for syncytiotrophoblastic cells.
Related Concept Videos
Mitogens and the Cell Cycle
Enzyme-linked Receptors
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway
